Clinical trials for Lymphoma
93 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
Lymphoma
CLL & Richter's syndrome
Acute leukemia
#NCT04707300
#2019-004883-23
Required histologic types
CLL (Chronic Lymphocytic Leukemia)
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
4 recruiting sites
Assistance Publique - Hôpitaux de Paris
Phase 1 / Phase 2
Lymphoma
#NCT05607420
#2022-501607-27-00
Partie escalade de dose
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Primary mediastinal lymphoma
Mantel cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
MALT lymphoma
Indolent transformed lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
2
3 or more
Required previous treatments
Chemotherapy
Monoclonal antibodies
Excluded previous treatments
Systemic Treatment-Naive
Car-T
4 recruiting sites
Cellectis SA
Phase 1 / Phase 2
Lymphoma
#NCT05607420
#2022-501607-27-00
Partie extension de dose
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Follicular lymphoma
Indolent transformed lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
2
3 or more
Required previous treatments
Chemotherapy
Monoclonal antibodies
Excluded previous treatments
Systemic Treatment-Naive
Car-T
4 recruiting sites
Cellectis SA
Phase 1 / Phase 2
Lymphoma
#NCT06495723
#2023-509648-88-00
Escalade et extension de dose
Required histologic types
T cell lymphoma
Required histologic sub types
Peripheral T cell lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Chemotherapy
Excluded previous treatments
Systemic Treatment-Naive
5 recruiting sites
Xenothera SAS
Phase 1 / Phase 2
Lymphoma
#NCT04669171
#2023-509254-58-00
Required histologic types
B cell lymphoma
Required histologic sub types
Follicular lymphoma
Marginal zone lymphoma
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Immunotherapy
Allogeneic stem cell transplant
1 recruiting site
Entérome
Phase 1 / Phase 2
Lymphoma
CLL & Richter's syndrome
#NCT06542250
#2024-511099-34-00
Required histologic types
B cell lymphoma
CLL (Chronic Lymphocytic Leukemia)
Required histologic sub types
Large B cell lymphoma
Mantel cell lymphoma
Follicular lymphoma
Lymphocytic lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
2 recruiting sites
AstraZeneca
Phase 1 / Phase 2
Lymphoma
#NCT04669171
#2023-509254-58-00
Required histologic types
B cell lymphoma
Required histologic sub types
Follicular lymphoma
Marginal zone lymphoma
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Excluded previous treatments
Allogeneic stem cell transplant
1 recruiting site
Entérome
Phase 1 / Phase 2
Lymphoma
#NCT07018752
#2024-514954-63-00
Required histologic types
T cell lymphoma
Required histologic sub types
Peripheral T cell lymphoma
Required central nervous system lesions
None
Required renal function statuses
> 60 ml/min
50-60 ml/min
30-50 ml/min
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
13 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 1
Lymphoma
#NCT07308132
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Primary mediastinal lymphoma
Required central nervous system lesions
None
Treated / Controled
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Chemotherapy
Monoclonal antibodies
Excluded previous treatments
Systemic Treatment-Naive
3 recruiting sites
Janssen
Phase 1
Breast cancer
Lung cancer
Pancreas cancer
Lymphoma
CLL & Richter's syndrome
Ovarian / Fallopian tubes / Peritoneum cancer
Sarcoma and GIST
#NCT06823167
#2025-523160-20-00
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Mesothelium
B cell lymphoma
Richter's syndrome
Epithelial ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer (PPC)
Soft tissue sarcoma
Required histologic sub types
Non-squamous NSCLC
Large B cell lymphoma
Mantel cell lymphoma
Follicular lymphoma
Lymphocytic lymphoma
Required HER2 statuses
HER2 Negative
Required HR statuses
HR Negative
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
3 recruiting sites
Immunome, Inc.